Abstract
Non-coding RNAs, especially lncRNAs, have emerged as key components in histone modification. The alterations in the epigenetic modifications of lncRNAs underlie some human disorders ranging from neurodegeneration to cancer. To characterize the epigenetic modifications of lncRNAs, we first constructed the histone modification maps of various epigenetic markers across different cell lines. Then, we developed a method to identify epigenetically regulated lncRNAs and their response genes by integrating large scale epigenetic and transcriptional profiles. Our results showed that epigenetic alterations at the promoters of lncRNAs can influence their expression and the negative response genes of most epigenetically regulated lncRNAs were enriched for PRC2-binding genes. At last, we inferred some lncRNAs with aberrant epigenetic modifications in glioblastoma and Alzheimer’s disease, and proved that theses lncRNAs may contribute to the initiation of human diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Derrien T, Johnson R, Bussotti G et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22:1775–1789
Cabili MN, Trapnell C, Goff L et al (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25:1915–1927
Washietl S, Kellis M, Garber M (2014) Evolutionary dynamics and tissue specificity of human long noncoding RNAs in six mammals. Genome Res 24:616–628
Ponting CP, Oliver PL, Reik W (2009) Evolution and functions of long noncoding RNAs. Cell 136:629–641
Lee JT (2012) Epigenetic regulation by long noncoding RNAs. Science 338:1435–1439
Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861–874
Qureshi IA, Mattick JS, Mehler MF (2010) Long non-coding RNAs in nervous system function and disease. Brain Res 1338:20–35
Spizzo R, Almeida MI, Colombatti A et al (2012) Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31:4577–4587
Prensner JR, Chinnaiyan AM (2011) The emergence of lncRNAs in cancer biology. Cancer Discov 1:391–407
Lee JT (2009) Lessons from X-chromosome inactivation: long ncRNA as guides and tethers to the epigenome. Genes Dev 23:1831–1842
Chu C, Qu K, Zhong FL et al (2011) Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell 44:667–678
Tsai MC, Manor O, Wan Y et al (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329:689–693
Kino T, Hurt DE, Ichijo T et al (2010) Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal 3:ra8
Fatica A, Bozzoni I (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15:7–21
Wu SC, Kallin EM, Zhang Y (2010) Role of H3K27 methylation in the regulation of lncRNA expression. Cell Res 20:1109–1116
Hangauer MJ, Vaughn IW, McManus MT (2013) Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet 9:e1003569
Sati S, Ghosh S, Jain V et al (2012) Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci. Nucleic Acids Res 40:10018–10031
Langmead B, Trapnell C, Pop M et al (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25
Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111
Hon GC, Hawkins RD, Caballero OL et al (2012) Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res 22:246–258
Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11:R106
Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550
Bernstein BE, Mikkelsen TS, Xie X et al (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315–326
Lundberg E, Fagerberg L, Klevebring D et al (2010) Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 6:450
Kugel JF, Goodrich JA (2012) Non-coding RNAs: key regulators of mammalian transcription. Trends Biochem Sci 37:144–151
Liao Q, Liu C, Yuan X et al (2011) Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res 39:3864–3878
Vaquerizas JM, Kummerfeld SK, Teichmann SA et al (2009) A census of human transcription factors: function, expression and evolution. Nat Rev Genet 10:252–263
Loewer S, Cabili MN, Guttman M et al (2010) Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet 42:1113–1117
Martens-Uzunova ES, Bottcher R, Croce CM et al (2014) Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol 65:1140–1151
French PJ, Peeters J, Horsman S et al (2007) Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. Cancer Res 67:5635–5642
Managadze D, Rogozin IB, Chernikova D et al (2011) Negative correlation between expression level and evolutionary rate of long intergenic non-coding RNAs. Genome Biol Evol 3:1390–1404
Zhang X, Sun S, Pu JK et al (2012) Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis 48:1–8
Qureshi IA, Mehler MF (2013) Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy. Neurother: J Am Soc Exp Neurother 10:632–646
Zhang B, Gaiteri C, Bodea LG et al (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell 153:707–720
Rogers J, Lue LF (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer’s disease. Neurochem Int 39:333–340
Airavaara M, Pletnikova O, Doyle ME et al (2011) Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. J Biol Chem 286:45093–45102
Schug J, McKenna LB, Walton G et al (2013) Dynamic recruitment of microRNAs to their mRNA targets in the regenerating liver. BMC Genomics 14:264
Zuchner S, Gilbert JR, Martin ER et al (2008) Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3. Ann Hum Genet 72:725–731
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Xiao, Y., Xu, J., Yin, W. (2018). Aberrant Epigenetic Modifications of Non-coding RNAs in Human Disease. In: Li, X., Xu, J., Xiao, Y., Ning, S., Zhang, Y. (eds) Non-coding RNAs in Complex Diseases. Advances in Experimental Medicine and Biology, vol 1094. Springer, Singapore. https://doi.org/10.1007/978-981-13-0719-5_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-0719-5_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0718-8
Online ISBN: 978-981-13-0719-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)